5-fluoropyrimidine has been researched along with Esophageal Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Gubat, JA; Liu, M; Liu, X; Lu, L; Min, L; Wang, M; Wang, T; Yu, J; Zhang, X; Zhu, C | 1 |
Jang, J; Kang, SY; Kim, KM; Lee, J; MacConaill, L; Maeng, CH; Palescandolo, E; Park, HY; Park, SH; Shim, YM; van Hummelen, P | 1 |
Bacsó, Z; Eliason, JF; Megyeri, A; Shields, A | 1 |
1 review(s) available for 5-fluoropyrimidine and Esophageal Neoplasms
Article | Year |
---|---|
The benefit of taxane-based therapies over fluoropyrimidine plus platinum (FP) in the treatment of esophageal cancer: a meta-analysis of clinical studies.
Topics: Antineoplastic Agents; Bridged-Ring Compounds; Esophageal Neoplasms; Humans; Organoplatinum Compounds; Pyrimidines; Taxoids | 2019 |
1 trial(s) available for 5-fluoropyrimidine and Esophageal Neoplasms
Article | Year |
---|---|
High-throughput genotyping in metastatic esophageal squamous cell carcinoma identifies phosphoinositide-3-kinase and BRAF mutations.
Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Amino Acid Substitution; Carcinoma, Squamous Cell; Class I Phosphatidylinositol 3-Kinases; Disease-Free Survival; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Mutation, Missense; MutL Protein Homolog 1; Neoplasm Metastasis; Nuclear Proteins; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins B-raf; Pyrimidines; Survival Rate; Tumor Suppressor Protein p53 | 2012 |
1 other study(ies) available for 5-fluoropyrimidine and Esophageal Neoplasms
Article | Year |
---|---|
Development of a stereological method to measure levels of fluoropyrimidine metabolizing enzymes in tumor sections using laser scanning cytometry.
Topics: Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Dihydrouracil Dehydrogenase (NADP); Esophageal Neoplasms; Floxuridine; Fluorescent Antibody Technique; Fluorescent Dyes; Humans; Laser Scanning Cytometry; Neoplasms; Pyrimidines; Thymidine Phosphorylase | 2005 |